These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23480776)

  • 41. Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria.
    Ronceray L; Dworzak M; Dieckmann K; Ebetsberger-Dachs G; Glogova E; Haas OA; Jones N; Nebral K; Moser R; Lion T; Meister B; Panzer-Grümayer R; Strehl S; Peters C; Pötschger U; Urban C; Mann G; Attarbaschi A;
    Wien Klin Wochenschr; 2024 Jul; 136(13-14):405-418. PubMed ID: 37535134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Schrøder H; Kjeldstad M; Boesen AM; Nielsen OJ; Schmidt KG; Johnsen HE; Gregersen H; Gustafsson G
    Ugeskr Laeger; 2006 Jun; 168(26-32):2554-8. PubMed ID: 16824410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of acute lymphoblastic leukemia in children according to the ALL-BFM-90m protocol in the Russian Federation and the Republic of Belarus].
    Miakova NV; Aleĭnikova OV; Hartmann R; Rudneva AE; Trubina NM; Fechina LG; Timakov AM; Shamardina AV; Lebedev VV; Varfolomeeva SIu; Dudkin SD; Dyshlevaia ZM; Timofeeva VN; Rumiantsev AG; Henze H; Karachunskiĭ AI
    Vopr Onkol; 2002; 48(3):347-51. PubMed ID: 12455360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004.
    Kamps WA; van der Pal-de Bruin KM; Veerman AJ; Fiocco M; Bierings M; Pieters R
    Leukemia; 2010 Feb; 24(2):309-19. PubMed ID: 20016528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).
    Kamps WA; Bökkerink JP; Hakvoort-Cammel FG; Veerman AJ; Weening RS; van Wering ER; van Weerden JF; Hermans J; Slater R; van den Berg E; Kroes WG; van der Does-van den Berg A
    Leukemia; 2002 Jun; 16(6):1099-111. PubMed ID: 12040440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
    Barry E; DeAngelo DJ; Neuberg D; Stevenson K; Loh ML; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin M; Cohen HJ; Sallan SE; Silverman LB
    J Clin Oncol; 2007 Mar; 25(7):813-9. PubMed ID: 17327603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
    Creutzig U; Zimmermann M; Ritter J; Reinhardt D; Hermann J; Henze G; Jürgens H; Kabisch H; Reiter A; Riehm H; Gadner H; Schellong G
    Leukemia; 2005 Dec; 19(12):2030-42. PubMed ID: 16304570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
    Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
    Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
    Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
    Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial.
    Uyttebroeck A; Suciu S; Laureys G; Robert A; Pacquement H; Ferster A; Marguerite G; Mazingue F; Renard M; Lutz P; Rialland X; Mechinaud F; Cavé H; Baila L; Bertrand Y;
    Eur J Cancer; 2008 Apr; 44(6):840-6. PubMed ID: 18342502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL97 study.
    Li CK; Chik KW; Ha SY; Lee AC; Yuen HL; Ling SC; Lee V; Chan GC; Shing MM; Chan LC; Ng MH
    Hong Kong Med J; 2006 Feb; 12(1):33-9. PubMed ID: 16495587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.
    Conter V; Aricò M; Basso G; Biondi A; Barisone E; Messina C; Parasole R; De Rossi G; Locatelli F; Pession A; Santoro N; Micalizzi C; Citterio M; Rizzari C; Silvestri D; Rondelli R; Lo Nigro L; Ziino O; Testi AM; Masera G; Valsecchi MG;
    Leukemia; 2010 Feb; 24(2):255-64. PubMed ID: 20016536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
    Dördelmann M; Schrappe M; Reiter A; Zimmermann M; Graf N; Schott G; Lampert F; Harbott J; Niemeyer C; Ritter J; Dörffel W; Nessler G; Kühl J; Riehm H
    Leukemia; 1998 May; 12(5):645-51. PubMed ID: 9593260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
    Schrappe M; Reiter A; Zimmermann M; Harbott J; Ludwig WD; Henze G; Gadner H; Odenwald E; Riehm H
    Leukemia; 2000 Dec; 14(12):2205-22. PubMed ID: 11187912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
    Moriya K; Imamura T; Katayama S; Kaino A; Okamoto K; Yokoyama N; Uemura S; Kitazawa H; Sekimizu M; Hiramatsu H; Usami I; Ishida H; Hasegawa D; Hama A; Moriya-Saito A; Sato A; Sasahara Y; Suenobu S; Horibe K; Hara J;
    Br J Haematol; 2022 Mar; 196(5):1257-1261. PubMed ID: 34879431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic.
    Volejnikova J; Jarosova M; Pospisilova D; Novak Z; Vrbkova J; Hajduch M; Mihal V
    Neoplasma; 2016; 63(3):456-61. PubMed ID: 26925793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.